Castelli, Letizia
De Giglio, Laura
Haggiag, Shalom
Traini, Arianna
De Luca, Francesca
Ruggieri, Serena
Prosperini, Luca http://orcid.org/0000-0003-3237-6267
Article History
Received: 13 June 2019
Accepted: 30 December 2019
First Online: 9 January 2020
Compliance with ethical standards
:
: None related to this article.
: The present study was conducted after approval of the Local Ethics Committee. All data were gathered after informed consent was obtained from each participant, in accordance with specific national laws and the ethics standards laid down in the 1964 Declaration of Helsinki and its later amendments. In no way this study did interfere in the care received by patients. Anonymized data will be shared upon request by the corresponding author (LP).
: LC: consulting fees from Almirall; LDG: travel grants from Biogen, Novartis, and Teva; LP: consulting fees from Biogen, Novartis and Roche; speaker honoraria from Biogen, Genzyme, Merck Serono, Novartis, and Teva; travel grants from Biogen, Genzyme, Novartis, and Teva; research grants from the Italian MS Society (Associazione Italiana Sclerosi Multipla) and Genzyme; SH, AT, FDL: none to declare.